Plasma apelin and ADMA Levels in patients with essential hypertension.
about
Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes.Plasma asymmetric dimethylarginine and L-arginine levels in Chinese patients with essential hypertension without coronary artery disease.Correlative studies on the effects of obesity, diabetes and hypertension on gene expression in omental adipose tissue of obese womenSerum apelin is associated with left ventricular hypertrophy in untreated hypertension patients.Associations of common variants at APLN and hypertension in Chinese subjects with and without diabetes.Organic nitrates favor regression of left ventricular hypertrophy in hypertensive patients on chronic peritoneal dialysis.Effects of Controlled Cortical Impact on the Mouse Brain Vasculome.Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart FailureThe role of nutrition and nutraceutical supplements in the treatment of hypertensionTreatment-associated change in apelin concentration in patients with hypertension and its relationship with left ventricular diastolic function.A promoter polymorphism in APJ gene is significantly associated with blood pressure changes and hypertension risk in Chinese womenUpdate on apelin peptides as putative targets for cardiovascular drug discovery.Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease.Apelin/APJ system: a promising therapy target for hypertension.What are the metabolic precursors which increase the risk of pre-eclampsia and how could these be investigated further.Agonist-induced internalization and desensitization of the apelin receptor.Lowered circulating apelin is significantly associated with an increased risk for hypertension: A meta-analysis.Masked hypertension and atherogenesis: the impact of apelin and relaxin plasma levels.Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis.Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.Predictive value of apelin-12 in patients with ST-elevation myocardial infarction with different renal function: a prospective observational study.Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.Apelin and APLN single nucleotide polymorphisms and combined hypertension and central retinal artery stenosis in a Chinese population.Plasma apelin levels, blood pressure and cardiovascular risk factors in a coastal Chinese population.Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells.The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer.Apelin, Plasmatic Osmolality and Hypotension in Dialyzed PatientsBlockade of Rostral Ventrolateral Medulla Apelin Receptors Does Not Attenuate Arterial Pressure in SHR and -NAME-Induced Hypertensive Rats
P2860
Q34163846-3D381A28-C2EB-4586-9EFB-D2D8279D3233Q35366321-90CE8EEE-251B-476B-A5A4-2BA294478585Q35825797-B84C728F-D2B4-4CEA-806B-F0151EF1499AQ36030356-87C622CB-4591-466C-A4D8-58F1F884BBFBQ36499842-82B3B64A-3D8E-42A7-BB34-17B18A6ED5D4Q36590001-B64D2A03-03AB-4623-B47C-D83E78C2CC44Q37062141-B8DFB9E7-F639-48B4-944C-EF3B5DFA690DQ37448653-980DF456-0A1C-47FE-B54C-7B62930E6CC7Q37603725-FF51C576-FFCE-40CF-91C8-B2C72B0BB22BQ37680306-F4251399-D56B-4DD2-9F59-53B4229E123AQ37699223-21039080-78C8-47E3-A461-4D902E8997CAQ38014484-58BF89FB-E9FC-4F1E-9073-3F0FB4610EA6Q38188874-8B76B790-C804-436A-A5C9-3F63A33DE4FFQ38225832-EAE7437F-E6A7-47D9-A776-7E7B4401C1C7Q38601790-D19931CD-5227-4145-B64F-52944BB79A37Q38753740-E0CD4798-5CBF-40EA-B40D-B41B9E841760Q38769363-03AC4CF6-7921-4C1E-BB83-D71AD4FCB0DCQ39430511-FD9AD461-D983-408F-B486-FFAE91F7B45EQ41972153-C8E4C77C-E8B2-49EE-A708-B6FA0D40C987Q42124925-8EACE747-6291-48E8-8BF8-AD283A654C8CQ47117248-B41FECEB-8FEB-4987-822E-68CAFEA03227Q51369856-E5DB1194-C34B-4354-8AE8-1B07DC98F94BQ53096243-BFA39587-29A3-4BED-A55C-799D184C8B32Q53102268-D0BA7881-726B-4927-B386-B4CB5F5C9054Q54515093-839B1A69-7752-4979-9686-1023B130EFEFQ54948644-68AF6030-FA45-4B11-8656-BEE4B2265DECQ58912060-076C34C9-BFE4-4D24-AAF6-EE1201346486Q59127752-69C5C997-F417-455F-A66E-6F80E671AEE2
P2860
Plasma apelin and ADMA Levels in patients with essential hypertension.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Plasma apelin and ADMA Levels in patients with essential hypertension.
@en
Plasma apelin and ADMA Levels in patients with essential hypertension.
@nl
type
label
Plasma apelin and ADMA Levels in patients with essential hypertension.
@en
Plasma apelin and ADMA Levels in patients with essential hypertension.
@nl
prefLabel
Plasma apelin and ADMA Levels in patients with essential hypertension.
@en
Plasma apelin and ADMA Levels in patients with essential hypertension.
@nl
P2093
P2860
P1476
Plasma apelin and ADMA Levels in patients with essential hypertension.
@en
P2093
Alper Sonmez
Cemal Nuri Ercin
Gokhan Erdem
Gokhan Uckaya
Gurkan Celebi
Halil Genc
Ilker Tasci
Mahmut Ilker Yilmaz
Mehmet Kemal Erbil
Mustafa Kutlu
P2860
P304
P356
10.3109/10641960903254505
P577
2010-05-01T00:00:00Z